Literature DB >> 19072134

Circulating CD23+ B cell subset correlates with the development of resistance to Schistosoma mansoni reinfection in occupationally exposed adults who have undergone multiple treatments.

Pauline N M Mwinzi1, Lisa Ganley-Leal, Carla L Black, W Evan Secor, Diana M S Karanja, Daniel G Colley.   

Abstract

BACKGROUND: Elevated immunoglobulin E (IgE) levels are often associated with resistance to reinfection in human schistosomiasis. However, Although B cells are the source of schistosome-specific IgE, little is known about B cell subsets or their functions in this infection. We evaluated B cells and their expression of the low-affinity IgE receptor (CD23) in a unique cohort of men occupationally exposed to Schistosoma mansoni and longitudinally followed up through multiple treatments with praziquantel, cures, and reinfections.
METHODS: Resistance levels were calculated on the basis of documented water exposure and reinfection data over many years. The CD23(+) B cell subset was evaluated in whole blood by flow cytometry. Serum antibody isotype and soluble CD23 (sCD23) concentrations were measured by enzyme-linked immunosorbent assay.
RESULTS: Expression of membrane CD23 (mCD23) on B cells correlated with the development of resistance against S. mansoni. Higher levels of plasma sCD23, the cleaved form of mCD23, also correlated with resistance and other markers of resistance to reinfection, such as eosinophilia.
CONCLUSIONS: CD23 may be involved in the development of resistance to schistosome infection through its role in IgE regulation. Understanding these complex host-parasite interactions may lead to insights into the development, mechanisms, and regulation of resistance to reinfection with S. mansoni.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19072134      PMCID: PMC2636678          DOI: 10.1086/595792

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

Review 1.  Vaccine-linked chemotherapy: can schistosomiasis control benefit from an integrated approach?

Authors:  N Robert Bergquist; Lydia R Leonardo; Graham F Mitchell
Journal:  Trends Parasitol       Date:  2005-03

2.  Schistosomiasis japonica in the Philippines: the long-term impact of population-based chemotherapy on infection, transmission, and morbidity.

Authors:  R M Olveda; B L Daniel; B D Ramirez; G D Aligui; L P Acosta; P Fevidal; E Tiu; F de Veyra; P A Peters; R Romulo; E Domingo; P M Wiest; G R Olds
Journal:  J Infect Dis       Date:  1996-07       Impact factor: 5.226

3.  Soluble CD21 (sCD21) forms biologically active complexes with CD23: sCD21 is present in normal plasma as a complex with trimeric CD23 and inhibits soluble CD23-induced IgE synthesis by B cells.

Authors:  V Frémeaux-Bacchi; E Fischer; S Lecoanet-Henchoz; J C Mani; J Y Bonnefoy; M D Kazatchkine
Journal:  Int Immunol       Date:  1998-10       Impact factor: 4.823

4.  Early expansion of secondary B cells after primary immunization with antigen complexed with IgE.

Authors:  S Westman; S Gustavsson; B Heyman
Journal:  Scand J Immunol       Date:  1997-07       Impact factor: 3.487

5.  Association between IgE antibody against soluble egg antigen and resistance to reinfection with Schistosoma japonicum.

Authors:  Z Zhang; H Wu; S Chen; L Hu; Z Xie; Y Qiu; C Su; J P Cao; Y Wu; S Zhang; G Wu
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Sep-Oct       Impact factor: 2.184

6.  In infection with Schistosoma mansoni, B cells are required for T helper type 2 cell responses but not for granuloma formation.

Authors:  H J Hernandez; Y Wang; M J Stadecker
Journal:  J Immunol       Date:  1997-05-15       Impact factor: 5.422

7.  Studies on schistosomiasis in western Kenya: II. Efficacy of praziquantel for treatment of schistosomiasis in persons coinfected with human immunodeficiency virus-1.

Authors:  D M Karanja; A E Boyer; M Strand; D G Colley; B L Nahlen; J H Ouma; W E Secor
Journal:  Am J Trop Med Hyg       Date:  1998-08       Impact factor: 2.345

8.  Human blood IgM "memory" B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire.

Authors:  Sandra Weller; Moritz C Braun; Bruce K Tan; Andreas Rosenwald; Corinne Cordier; Mary Ellen Conley; Alessandro Plebani; Dinakhanta S Kumararatne; Damien Bonnet; Olivier Tournilhac; Gil Tchernia; Birte Steiniger; Louis M Staudt; Jean-Laurent Casanova; Claude-Agnès Reynaud; Jean-Claude Weill
Journal:  Blood       Date:  2004-06-10       Impact factor: 22.113

9.  Antigen presentation is enhanced by targeting antigen to the Fc epsilon RII by antigen-anti-Fc epsilon RII conjugates.

Authors:  C M Squire; E J Studer; A Lees; F D Finkelman; D H Conrad
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

10.  Negative feedback regulation of IgE synthesis by murine CD23.

Authors:  P Yu; M Kosco-Vilbois; M Richards; G Köhler; M C Lamers
Journal:  Nature       Date:  1994-06-30       Impact factor: 49.962

View more
  28 in total

1.  Immuno-evasive tactics by schistosomes identify an effective allergy preventative.

Authors:  Qyana Griffith; YanMei Liang; Patrick Whitworth; Carlos Rodriguez-Russo; Ahmad Gul; Afzal A Siddiqui; John Connor; Pauline Mwinzi; Lisa Ganley-Leal
Journal:  Exp Parasitol       Date:  2015-03-24       Impact factor: 2.011

2.  CD23b isoform expression in human schistosomiasis identifies a novel subset of activated B cells.

Authors:  Daniel Onguru; YanMei Liang; Jennifer Elliot; Pauline Mwinzi; Lisa Ganley-Leal
Journal:  Infect Immun       Date:  2011-06-27       Impact factor: 3.441

Review 3.  Schistosomiasis in the People's Republic of China: the era of the Three Gorges Dam.

Authors:  Donald P McManus; Darren J Gray; Yuesheng Li; Zheng Feng; Gail M Williams; Donald Stewart; Jose Rey-Ladino; Allen G Ross
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

Review 4.  Schistosomiasis vaccines.

Authors:  Afzal A Siddiqui; Bilal A Siddiqui; Lisa Ganley-Leal
Journal:  Hum Vaccin       Date:  2011-11-01

5.  Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.

Authors:  Carla L Black; Erick M O Muok; Pauline N M Mwinzi; Jennifer M Carter; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  J Infect Dis       Date:  2010-08-15       Impact factor: 5.226

6.  Human schistosomiasis is associated with endotoxemia and Toll-like receptor 2- and 4-bearing B cells.

Authors:  Daniel Onguru; Yanmei Liang; Qyana Griffith; Barbara Nikolajczyk; Pauline Mwinzi; Lisa Ganley-Leal
Journal:  Am J Trop Med Hyg       Date:  2011-02       Impact factor: 2.345

7.  Influence of exposure history on the immunology and development of resistance to human Schistosomiasis mansoni.

Authors:  Carla L Black; Pauline N M Mwinzi; Erick M O Muok; Bernard Abudho; Colin M Fitzsimmons; David W Dunne; Diana M S Karanja; W Evan Secor; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2010-03-23

Review 8.  Immunological and Biochemical Interplay between Cytokines, Oxidative Stress and Schistosomiasis.

Authors:  Priscilla Masamba; Abidemi Paul Kappo
Journal:  Int J Mol Sci       Date:  2021-07-05       Impact factor: 5.923

Review 9.  Regulation of pathogenesis and immunity in helminth infections.

Authors:  Rick M Maizels; Edward J Pearce; David Artis; Maria Yazdanbakhsh; Thomas A Wynn
Journal:  J Exp Med       Date:  2009-09-21       Impact factor: 14.307

10.  Impact of intense, longitudinal retreatment with praziquantel on cure rates of schistosomiasis mansoni in a cohort of occupationally exposed adults in western Kenya.

Authors:  Carla L Black; Michelle L Steinauer; Pauline N M Mwinzi; W Evan Secor; Diana M S Karanja; Daniel G Colley
Journal:  Trop Med Int Health       Date:  2009-02-14       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.